People channel feed

Galec­to lays off 70% of staff, con­sid­ers strate­gic al­ter­na­tives af­ter IPF tri­al fail

31 minutes ago

Force­field Ther­a­peu­tics to start £35M Se­ries A in Oc­to­ber af­ter scoop­ing ex-No­var­tis ex­ec John Tsai as new CEO

2 hours ago
Financing

Ex­clu­sive: Deep­Mind’s Demis Has­s­abis un­veils his vi­sion for Iso­mor­phic and AI’s fu­ture in biotech

20 hours ago
AI

Pox­el takes write­down on NASH drug as it con­tin­ues lay­offs, search for cash

23 hours ago
Pharma

Im­mu­ni­ty­Bio lays off 50 em­ploy­ees in Flori­da and Cal­i­for­nia af­ter blad­der can­cer BLA re­jec­tion

2 days ago

Au­rinia ap­points founder to board in hand­shake with MKT Cap­i­tal

5 days ago

Up­dat­ed: So­ci­etal CD­MO lays off 26 em­ploy­ees, re­works hir­ing plans af­ter strat­e­gy re­view

6 days ago
Manufacturing

Ox­ford Bio­med­ica piv­ots by lay­ing off 200 peo­ple, ac­quir­ing ABL Eu­rope amid de­clin­ing to­tal rev­enues

6 days ago
Manufacturing

NightHawk lays off 14% of R&D work­force, piv­ots to fo­cus on CD­MO Scor­pius Bio­man­u­fac­tur­ing

6 days ago
Manufacturing

It’s al­most the end of the road for Fresh Tracks as board sup­ports liq­ui­da­tion

Last week
Pharma

Rentschler names Benedikt von Braun­muehl as CEO; Catal­ent grabs David McEr­lane from Lon­za as bi­o­log­ics lead

Last week
Manufacturing

Kin­nate lays off 70% of em­ploy­ees, shaves pipeline to fo­cus on CDK4 and pan-RAF in­hibitor

Last week
R&D

Mer­ck’s women’s health spin­off Organon looks for phar­ma­ceu­ti­cals, di­ag­nos­tics, de­vices to fill out its pipeline

Last week
Pharma

For­mer Alex­ion VP pleads guilty to in­sid­er trad­ing on Por­to­la buy­out

Last week
Law

Ex­clu­sive: GSK re­vamps its re­search strat­e­gy, build­ing three teams to tar­get spe­cif­ic dis­ease spaces

Last week
R&D
Pharma

No­bel lau­re­ate Car­olyn Bertozzi joins cell ther­a­py biotech Ace­po­dia as chief sci­en­tif­ic ad­vi­sor

Last week

Lon­za CEO Pierre-Alain Ruffieux to leave CD­MO amid re­duced growth

Last week
Manufacturing

Lyn­dra lays off 23% of work­ers, to out­source man­u­fac­tur­ing as it ap­proach­es piv­otal read­out next month

Last week
Startups

Ab­cam finds founder’s op­po­si­tion to Dana­her deal ‘sur­pris­ing,’ say­ing he's sow­ing 'con­fu­sion for share­hold­er­s'

Last week
Deals

Up­dat­ed: 2sev­en­ty lays off 40% of staff, prunes CAR-T pipeline as Nick Leschly steps down as CEO

2 weeks ago
Cell/Gene Tx

As­traZeneca ad­dress­es re­port that CEO Pas­cal So­ri­ot plans to de­part

3 weeks ago
Pharma

Bernie Sanders lifts hold on NIH nom­i­nee fol­low­ing Re­gen­eron price con­ces­sions

3 weeks ago
Coronavirus

Marc Tessier-Lav­i­gne steps down from Re­gen­eron board

3 weeks ago

NASH com­pa­ny Madri­gal names for­mer Sanofi ex­ec Bill Si­bold as new CEO

3 weeks ago
1234 Next page Last page
A service from the Financial Times